Quince Therapeutics, Inc. (QNCX)
NASDAQ: QNCX · Real-Time Price · USD
0.944
-0.033 (-3.34%)
At close: Jun 26, 2026, 4:00 PM EDT
0.959
+0.015 (1.63%)
After-hours: Jun 26, 2026, 7:56 PM EDT
Quince Therapeutics Employees
Quince Therapeutics had 38 employees as of December 31, 2025. The number of employees increased by 2 or 5.56% compared to the previous year.
Employees
38
Change (1Y)
2
Growth (1Y)
5.56%
Revenue / Employee
n/a
Profits / Employee
-$951,447
Market Cap
15.38M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Lunai Bioworks | 29 |
| Passage Bio | 24 |
| Citius Pharmaceuticals | 23 |
| Atossa Therapeutics | 16 |
| Werewolf Therapeutics | 14 |
| BioVie | 13 |
| Tempest Therapeutics | 5 |
| Exicure | 2 |
QNCX News
- 3 days ago - Quince Therapeutics initiated with an Outperform at Leerink - TheFly
- 4 days ago - Quince Therapeutics initiated with an Overweight at Cantor Fitzgerald - TheFly
- 4 days ago - Quince Therapeutics initiated with an Overweight at Cantor Fitzgerald - TheFly
- 5 weeks ago - UPDATE - Quince Therapeutics Announces Clinically Meaningful Improvements Across Functional, Hemodynamic and Biomarker Measures in Phase 2 Study in PAH and PH-ILD - GlobeNewsWire
- 5 weeks ago - Quince Therapeutics Transcript: Investor update - Transcripts
- 5 weeks ago - Quince Therapeutics Press release: Investor update - Filings
- 5 weeks ago - Quince Therapeutics Slides: Investor update - Filings
- 5 weeks ago - Quince Therapeutics announces LAM-001 data - TheFly